What is MedTrials?
MedTrials operates as a full-service contract research organization (CRO) with over two decades of specialized expertise in clinical trial management. The firm provides a comprehensive suite of services, including site management, data management, quality assurance, and professional training. By focusing on therapeutic areas such as ophthalmology, dermatology, cardiology, and gastroenterology, MedTrials serves as a critical link between pharmaceutical sponsors, medical device manufacturers, and clinical investigators. Their integrated technology solutions and commitment to rigorous data standards ensure that complex trials are executed within budget and on schedule, positioning them as a vital infrastructure provider in the global life sciences ecosystem.
How much funding has MedTrials raised?
MedTrials has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
Key Investors in MedTrials
PPP
Public-Private Partnership
What's next for MedTrials?
With this major enterprise-level funding, MedTrials is well-positioned to scale its service offerings and enhance its technological infrastructure. The strategic deployment of these funds will likely focus on expanding their footprint in high-growth therapeutic markets and optimizing their data management capabilities to meet the evolving demands of global clinical research. As the industry shifts toward more decentralized and technology-enabled trial models, MedTrials is expected to leverage this investment to maintain its competitive edge, ensuring that sponsors receive the reliable, high-quality data necessary for regulatory success and product commercialization. Future growth will likely be defined by their ability to integrate advanced analytics into their existing service framework, further cementing their reputation as a trusted partner in the clinical development lifecycle.
See full MedTrials company page
